Treatment Areas

Your New Role in the Battle Against Depression
Your New Role in the Battle Against DepressionA shortage of mental health-care providers, coupled with pharmacists’ unique skills and access to patients, has led to a significant opportunity for community and health-system pharmacists to aid in detection of depression and in medication selection and counseling for patients with depression.
Alzheimer's Disease: Untapped Potential for PharmacyPharmacists can become the perfect partner in the battle against Alzheimer’s disease. Details here.
CE: New options when statins are not enough
CE: New options when statins are not enoughThe goal of this activity is to prepare pharmacists with the knowledge they need to provide contemporary pharmacologic therapy to patients with hyperlipidemia.
Key cogs in the management of Parkinson’s disease
Key cogs in the management of Parkinson’s diseaseThe goal of this activity is to assist pharmacists in managing difficult-to-treat symptoms of Parkinson’s disease.
Are states going too far with painkiller script limits?Arizona has become the latest state to limit opioid prescriptions—a trend that has some healthcare providers and experts concerned.
A Class of Their Own: The Unique Challenges of Type I DiabetesWhile many aspects of diabetes care are universal, patients with type I diabetes (T1D) often face a unique set of obstacles and challenges.
How Pharmacies are Helping Patients with DiabetesWhen pharmacists get involved in patient care, significant improvements are often seen. Diabetes management is one of the most notable examples.
Update on Diabetes TherapyDespite evidence that optimal glycemic control can help reduce disease progression and complications, most patients do not achieve recommended treatment goals.
Anticoagulant therapies
Daclizumab approved for relapsing forms of multiple sclerosisDaclizumab is the first subcutaneous injectable monoclonal antibody to be approved for the treatment of MS.